News & Publications for:

Anne Fagan

Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.

Posted on July 23, 2013

Richard J. Perrin,Jacqueline E. Payton, James P. Malone, Petra Gilmore, Alan E. Davis, Chengjie Xiong, Anne M. Fagan, R. Reid Townsend, and David M. Holtzman,
Dulce Elena Casarini, Editor; PLoS One. 2013; 8(5): e64314.Published online 2013 May 20. doi: 10.1371/journal.pone.0064314
Read More

Posted in: HPAN, Publications Faculty: , ,

Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

Posted on June 27, 2013

Roe, C.M. , Fagan, A.M., Grant, E.A., Hassenstab, J., Moulder, K.L., Dreyfus, D.M., Sutphen, C.L., Benzinger, T.L.S., Mintun, M.A., Holtzman, D.M., Morris, J.C.;Neurology
Volume 80, Issue 19, 7 May 2013, Pages 1784-1791 Read More

Posted in: HPAN, Publications Faculty: , ,

Plasma multi-analyte profiling in mild cognitive impairment and Alzheimer’s disease

Posted on September 18, 2012

Hu WT, Holtzman DM, Fagan AM, Shaw LM, Perrin R, Arnold SE, Grossman M, Xiong C, Craig-Schapiro R, Clark CM, Pickering E, Kuhn M, Chen Y, Van Deerlin VM, McCluskey L, Elman L, Karlawish J, Chen-Plotkin A, Hurtig HI, Siderowf A, Swenson F, Lee VM, Morris JC, Trojanowski JQ, Soares H; For the Alzheimer’s Disease Neuroimaging Initiative (2012). Neurology, 79(9): 897-905 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty: , ,